Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma | Zendy

Anish Bhattacharya | Zendy; SunilHejjaji Venkataramarao | Zendy; ChandraSekhar Bal | Zendy; BhagwantRai Mittal | Zendy

Open Access

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma

Author(s) -

Anish Bhattacharya,

SunilHejjaji Venkataramarao,

ChandraSekhar Bal,

BhagwantRai Mittal

Publication year - 2010

Publication title -

indian journal of nuclear medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.261

H-Index - 13

eISSN - 0972-3919

pISSN - 0974-0244

DOI - 10.4103/0972-3919.63599

Subject(s) - medicine , thyroid carcinoma , thyroid cancer , nuclear medicine , radiology , radioiodine therapy , iodine , thyroid , papillary thyroid cancer , computed tomographic , thyroidectomy , computed tomography , metallurgy , materials science

The management protocol for differentiated thyroid cancer includes whole body iodine-131 imaging, to detect residual thyroid tissue and distant metastasis, after thyroidectomy. However, the diagnostic dose of radioiodine may fail to detect the non-functioning or poorly functioning metastasis. We present a case where hybrid single photon-emission computed tomographic and computed tomographic (SPECT-CT) fusion imaging, using a diagnostic dose of iodine-131, was able to detect both functioning as well as non-functioning pulmonary metastases, prior to high-dose radioiodine therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research